Tag: Alzheimer’s
Dronabinol Safe, Effective for Alzheimer Disease With Agitation
Authors are optimistic about the 'repurposing' of FDA-approved dronabinol
SGLT2i Use Linked to Lower Risk for Neurodegenerative Disease in T2DM
Reduced risk for Alzheimer disease, vascular dementia, and Parkinson disease seen with SGLT2i use in type 2 diabetes
Outdoor Nighttime Light Exposure Linked to Prevalence of Alzheimer Disease
Nighttime light exposure more strongly linked to AD prevalence than any other disease factor among those younger than 65 years
Multiple Sclerosis Linked to Lower Risk for Alzheimer Disease Pathology
Lower rate of amyloid-β plasma biomarker positivity seen in multiple sclerosis patients compared with non-MS controls
Regional Variation Seen in Alzheimer and Related Dementia Diagnosis
ADRD-specific diagnosis intensity varies most for Black, Hispanic, and youngest subgroups
Mix of Factors Can ID Cognitive Decline in Early Alzheimer Disease
Age, sex, irregular heart rhythm, and daily activity levels can predict cognitive decline and caregiver load over two years
Risk for Alzheimer Dementia Lower With Treated Versus Untreated HTN
All-cause dementia risk greater for those with treated and untreated hypertension compared with healthy controls
HbA1c Stability Tied to Lower Risk for Alzheimer Disease and Related Dementias
Findings seen in large study of older veterans with diabetes
Plasma Biomarkers of Alzheimer Neuropathy Linked to Dementia Risk
Significant associations seen for all Alzheimer disease plasma biomarkers in late life with late-life dementia
Amyloid Probability Score 2 Has High Diagnostic Accuracy for Alzheimer Disease
Diagnostic accuracy 73 percent for dementia specialists compared with 91 percent using the APS2
